Clinical Trial Update: Dose-escalation and Food Effect Study of ZT006 in Healthy, Overweight and Obese Participants [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 dose-escalation and food-effect study of ZT006 in healthy and overweight/obese participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• ZT006

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Overweight,Obesity | Phase 1 | Status: COMPLETED